Blaj, S., & Piso, P. (2018). Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?. Current Issues in Pharmacy and Medical Sciences, 30(4), 207-210. https://doi.org/10.1515/cipms-2017-0040